Skip to content

Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.

Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07335731
Enrollment
50
Registered
2026-01-13
Start date
2025-07-10
Completion date
2027-07-30
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Robot Surgery

Brief summary

This study aims to obtain short-term clinical results on the safety and efficacy of single-port robot-assisted metabolic weight loss surgery, and to provide further evidence for the clinical promotion of single-port robot systems.

Interventions

DEVICERobot-assisted single-port bariatric surgery

For overweight or obese patients (BMI≥27.5kg/m2) who meet the indications for metabolic surgery, single-port robot-assisted sleeve gastrectomy or gastric bypass surgery is performed.

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ①Overweight or obese patients who meet the criteria for metabolic weight loss surgery, with a BMI ≥ 27.5 kg/m2; ② Patients who understand the purpose of the trial, voluntarily participate in the trial, and sign an informed consent form.

Exclusion criteria

* ① Patients who cannot tolerate general anesthesia, such as those with severe heart, lung, or liver dysfunction; ② Patients with severe coagulation disorders; ③ Pregnant patients; ④ Patients with concurrent tumors; ⑤ Patients with extensive and severe abdominal adhesions that prevent the establishment of pneumoperitoneum; ⑥ A BMI \> 50 kg/m² is a relative contraindication; ⑦ Patients deemed unsuitable for participation in this trial by any other investigator.

Design outcomes

Primary

MeasureTime frame
Percentage of weight lossPostoperative 1 month, 3 months, 6 months, 12months

Secondary

MeasureTime frame
blood pressure1 month, 3 months, 6 months, and 12 months post-surgery
operation timeIntraoperative
Postoperative complications (postoperative bleeding, gastric leakage, anastomotic leakage, abdominal infection, incisional hernia, etc.)12 months post-surgery
Physician fatigue level (Visual Analogue Scale)1 day after surgery
blood sugar1 month, 3 months, 6 months, and 12 months post-surgery
body fat percentage1 month, 3 months, 6 months, and 12 months post-surgery
estimated blood loss1 month after surgery
conversion to laparoscopic or open surgery1 month after surgery
30-day reoperation rate1 month after surgery
30-day readmission rate1 month after surgery
length of postoperative hospital stay1 month after surgery
Physician satisfaction level (Net Promoter Score, NPS)1 day after surgery

Countries

China

Contacts

CONTACTSIQi Wang
menghuade@hotmail.com18810315722

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026